-
Study aim
-
Comparison of efficacy of two methods haloperidol and ketamine with haloperidol and pethidine in comparison with control group in which the patients receive normal saline as placebo, on catheter related bladder discomfort (CRBD)
-
Design
-
A clinical trial with a community-based and pragmatic control group, with parallel groups, triple-blind, randomized.
119 male patients with laminectomy were divided into 3 groups: 1: 0.04 mg/kg haloperidol and 0.5 mg/kg ketamine in 5cc distilled water, 2: 0.04 mg/kg haloperidol and 0.5 mg/kg pethidine In 5 cc distilled water, intervention 3: In normal saline control group, they are randomly divided into placebo. Randomization method and description of each method: Simple randomization, randomization unit: Individual, randomization tool: random number table, clinical trial phase 2.
-
Settings and conduct
-
The main aim of the study is comparison of catheter-related bladder discomfort in the two methods of Haloperidol and Ketamine with Haloperidol and Pethidine in male patients after elective lumbar spine Laminectomy.
This double blinded randomized phase 2 clinical trial was done in Sina hospital of Tehran city.
119 male patients with laminectomy were divided into 3 groups: 1: 0.04 mg/kg haloperidol and 0.5 mg/kg ketamine in 5cc distilled water, 2: 0.04 mg/kg haloperidol and 0.5 mg/kg pethidine In 5 cc distilled water, intervention 3: In normal saline control group, they are randomly divided into placebo. Randomization method and description of each method: Simple randomization, randomization unit: Individual, randomization tool: random number table, clinical trial phase 2.
In this study, the patients, measuring the outcomes of study participants (researchers) or Data Monitoring Committee (analyzers) of the patients unaware about intervention.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: ASA class I and II, Male gender, Age between 18 and 70 years.
Exclusion criteria: Inability to extubate patients after surgery, history of urological surgery, patients who have any damage or distracting pain other than the site of surgery, patients with any lesion and central nervous system disease; patients with a history of chronic pain; patients with severe heart and liver disease or evidence of long QT segment in electrocardiography.
-
Intervention groups
-
Intervention 1: 0.04 mg/kg haloperidol and 0.5 mg/kg ketamine
Intervention 2: 0.04 mg/kg haloperidol and 0.5 mg/kg pethidine
Intervention 3: Normal saline as placebo
-
Main outcome variables
-
Bladder discomfort associated with, pain and sedation.